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enzymes during Giardia – host cell interactions
in vitro
Britta Stadelmann1, Kurt Hanevik2,3, Mattias K Andersson1, Oystein Bruserud2 and Staffan G Svärd1*Abstract
Background: Arginine is a conditionally essential amino acid important in growing individuals and under non-
homeostatic conditions/disease. Many pathogens interfere with arginine-utilization in host cells, especially nitric
oxide (NO) production, by changing the expression of host enzymes involved in arginine metabolism. Here we used
human intestinal epithelial cells (IEC) and three different isolates of the protozoan parasite Giardia intestinalis to
investigate the role of arginine and arginine-metabolizing enzymes during intestinal protozoan infections.
Results: RNA expression analyses of major arginine-metabolizing enzymes revealed the arginine-utilizing pathways
in human IECs (differentiated Caco-2 cells) grown in vitro. Most genes were constant or down-regulated (e.g.
arginase 1 and 2) upon interaction with Giardia, whereas inducible NO synthase (iNOS) and ornithine decarboxylase
(ODC) were up-regulated within 6 h of infection. Giardia was shown to suppress cytokine-induced iNOS expression,
thus the parasite has both iNOS inducing and suppressive activities. Giardial arginine consumption suppresses NO
production and the NO-degrading parasite protein flavohemoglobin is up-regulated in response to host NO. In
addition, the secreted, arginine-consuming giardial enzyme arginine deiminase (GiADI) actively reduces T-cell
proliferation in vitro. Interestingly, the effects on NO production and T cell proliferation could be reversed by
addition of external arginine or citrulline.
Conclusions: Giardia affects the host’s arginine metabolism on many different levels. Many of the effects can be
reversed by addition of arginine or citrulline, which could be a beneficial supplement in oral rehydration therapy.
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Giardia intestinalis (a.k.a. G. lamblia and G. duodena-
lis), a protozoan parasite, causes diarrhea in a wide var-
iety of host species [1]. Due to the broad spectrum of
hosts and genetic differences the parasite is divided into
8 assemblages (A to H) [2], of which two (A and B) are
responsible for approximately 300 million cases of hu-
man giardiasis yearly [2]. Giardiasis was included into
the WHO initiative for neglected diseases in 2004 [3].
Patients get infected upon ingestion of infectious cysts
in contaminated food or water that release proliferating
trophozoites in the duodenum, establishing intestinal
infection [1]. Roughly half of the infections stay asymp-* Correspondence: staffan.svard@icm.uu.se
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distribution, and reproduction in any mediumtomatic, whereas the other half results in disease. Symp-
toms of giardiasis include nausea, vomiting, epigastric pain
and watery diarrhea [4], though duration and symptoms
are highly variable. Giardiasis is associated with malabsorp-
tion, reduced growth and developmental retardation in
children [5], irritable bowel syndrome, arthritis and chronic
fatigue [6]. It is a multifactorial disease but most of the
virulence factors remain unknown [2,7].
G. intestinalis is able to degrade the amino acid argin-
ine as an energy source via the arginine dihydrolase
pathway [8] and two of the enzymes of this pathway,
arginine deiminase (ADI) and ornithine carbamoyltrans-
ferase (OCT), are released upon Giardia-intestinal epi-
thelial cell (IEC) interaction [9]. The parasite rapidly
reduces the amount of arginine in the growth medium
during in vitro growth [7], resulting in reduced prolifera-
tion of IECs. Infection of IECs with an assemblage Antral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(NO) production by these cells [10] since arginine is also
substrate for NO synthases (NOS). Giardia ADI was
identified as the protein being responsible for a reduced
NO response in in vitro interaction setups [9]. At least
in vitro, NO acts cytostatic against G. intestinalis tro-
phozoites and inhibits encystation and excystation [10],
the two differentiation processes essential for infection.
It plays a role in muscle relaxation and thus in mechan-
ical parasite elimination by peristalsis [11,12]. Therefore
reduction of the NO response of the host is in favor of
Giardia growth. More recently, a NO-detoxifying en-
zyme (flavohemoglobin) was found in G. intestinalis, but
its expression status upon host cell interaction has not
been addressed yet [13,14]. Therefore it needs to be in-
vestigated how exactly Giardia interferes with the NO
response of human IECs.
In mammalian cells, NO is formed either by NOS
(eNOS, NOS3 in endothelial cells, nNOS, NOS1 in
neuronal cells and iNOS, NOS2 in epithelial, endothelial
and inflammatory cells) through conversion of arginine
into citrulline and NO in an oxygen-dependent reaction,
or through reduction of nitrite in various oxygen-
independent ways [15]. NO has multiple roles in the
human body, broadly taken together, as a cellular mes-
senger and as an antimicrobial agent [15,16]. NO reacts
with reactive oxygen intermediates, forming antimicro-
bial substances such as nitrogen dioxide, peroxynitrite,
S-nitrosothiols, dinitrogen trioxide and dinitrogen tet-
roxide that will cause damage in the cell wall, the DNA
and the proteins of pathogens and also human cells [16].
However, effects of NO on Giardia trophozoites do not
seem to be exerted by peroxynitrite [17].
Many pathogens are known to interfere with the host’s
arginine metabolism. Salmonella typhimurium, Myco-
bacterium tuberculosis, Helicobacter pylori, Trypano-
soma brucei and T. cruzi, Toxoplasma gondii and
Schistosoma mansoni are known examples of pathogens
that compete with host NOS for their common substrate
arginine via up-regulation of host arginases [18,19].
Some microorganisms are even known to consume ar-
ginine via their own arginases [18,19]. Thereby patho-
gens can reduce host NO production and increase
polyamine synthesis, which is in favor of pathogen
growth and survival. However, within such studies it
has neither been addressed what functions arginine-
metabolizing enzymes apart from arginase or arginine
transporters could play, nor has the direct consumption
of arginine, or active detoxification of NO, by a pathogen
been taken into account.
As shown in previous microarray studies [20] a variety
of chemokines are induced upon Giardia-host cell inter-
action that would be potent in attracting immune cells
such as B and T cells, dendritic cells, macrophages,monocytes, mast cells and neutrophils to the intestinal
mucosa. For yet unknown reasons, Giardia-infection,
however, leads only to a small increase in intra-epithelial
lymphocytes and little or no mucosal inflammation in
human giardiasis patients [2,21]. It has recently been
shown that consumption of arginine and production of
ammonia via Giardia ADI affects the phenotype and
cytokine production of dendritic cells [22], but it is not
known if arginine depletion affects other immune cells.
In the present study we show effects of the intestinal
parasite Giardia on the innate and adaptive host im-
mune response by focusing on the parasite’s arginine-
consuming ability and the enzyme ADI in particular.
Effects on host cell’s NO production, expression of
arginine-consuming enzymes and T cell proliferation are
shown. We also investigated a NO-detoxification system
that the parasite induces NO-dependently upon host cell
interaction.
Results
Expression of arginine-consuming enzymes in human IECs
upon Giardia infection
Our earlier data showed that arginine is depleted in the
growth medium already after 1-2 h of in vitro interaction
between Giardia trophozoites and human IECs [7]. A
number of enzymes and transporters are directly and in-
directly involved in the arginine-metabolism of human
cells (Figure 1). Pathogenic microbes are known to affect
the expression of these enzymes, especially arginase 1
and 2 [18]. However, arginine-metabolism in human
IECs is poorly characterized and it is not known how it
is affected by Giardia infection. In order to study this,
the expression of arginine-consuming enzymes was
assessed in differentiated TC7 Caco-2 cells, that exhibit
small intestinal epithelial characteristics, by qPCR at
time points 0, 1.5, 3, 6 and 24 h post in vitro Giardia in-
fection. To study if different Giardia assemblages have
different effects on the arginine metabolism we used
trophozoites from three different isolates: WB (assem-
blage A), GS (assemblage B) and P15 (assemblage E) [2].
The assessed genes were the chemokine ccl20 as positive
infection control [20] and several arginine-consuming
enzymes (see Figure 1 and 2, Additional file 1: Table S1).
Except for cat2 and nos1, all tested genes were expressed
in IECs, however, adc, argI and nos3 only at very low
levels (Additional file 1: Tables S2-S4). Most of the genes
showed only slight changes in expression on RNA level
over the 24 h experiment (Figure 2). The strong induc-
tion of ccl20 already after 1.5 h of infection with Giardia
trophozoites is in line with our earlier results [20]. None
of the tested arginine-consuming enzymes were up-
regulated more than 2 times after 1.5 h of WB inter-
action. After 3 and 6 h, odc and nos2 were up-regulated
more than 2 times in the WB interaction, but expression
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Figure 1 RNA expression changes of arginine-consuming enzymes upon Giardia-host cell interaction. Based on an interpretation of
results from this and previous studies, the encircled numbers point out various ways by which Giardia interferes with the host immune response:
(1) consumption of arginine via arginine-ornithine antiporter, (2) release of arginine-consuming ADI and OCT, (3) blocking of arginine-uptake into
host cells by ornithine, (4) down-regulation of host iNOS, (5) up-regulation of host ODC, (6) up-regulation of parasite FlHb upon NO-stress.
Human intestinal epithelial cells (Caco-2) were in vitro interacted with Giardia trophozoites and the expression changes of arginine-consuming
enzymes were assessed by qPCR. Various enzymes involved in the arginine-metabolism of host cells and of Giardia are shown (adapted from
Stadelmann et al 2012 [7]). Changes in expression after 1.5, 3, 6 and 24 h as compared to 0 h are indicated for interactions with the parasite
isolate WB according to Figures 2 and 4 (square for no change, triangle pointing up for up-regulation, triangle pointing down for down-
regulation; cut-off value 2). Expression of inos and flhb in host cells that were stimulated with cytokines (TNF-α (200 ng/mL), IL-1α (200 ng/mL),
IFN-γ (500 ng/mL) to produce nitric oxide is also shown (non-filled triangles for up- and down-regulation, non-filled square for no change). ADC,
arginine decarboxylase; ADI, arginine deiminase; AGAT, arginine-glycine amidinotransferase; ARG, arginase; ASL, argininosuccinate lyase; ASS,
argininosuccinate synthetase; CAT, cationic amino acid transporter; CK, carbamate kinase; FlHb, flavohemoglobin; NO, nitric oxide; NOS, nitric oxide
synthase; OAT, ornithine aminotransferase; OCT, ornithine carbamoyl transferase; ODC, ornithine decarboxylase; p6C, Δ1-pyrroline-5-carboxylate.
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interactions with parasites of the isolates GS and P15.
However, the effects on induction of ccl20, nos2 and odc
were much more pronounced upon infection with the
isolate GS than with WB and P15 (Figure 2). arg1, arg2
and agat were down-regulated at all time points with a
4- (arg1), 3- (arg2) and 6.5-fold (agat) reduction at 6 h
of WB interaction, followed by recovery to near basal
expression levels after 24 h. This profile was also seen in
interactions with the two other isolates. Several other
genes (adc, oat, oct) showed the same expression profiles
with an initial decrease followed by an increase at 24 h.
Thus, upon depletion of arginine by Giardia trophozo-
ites (after 1-2 h), expression levels of most host arginine-
metabolizing enzymes are reduced, independent of the
parasite isolate. The results are summarized in Figure 1,
which shows the complex gene expression changes occur-
ring when Giardia trophozoites interact with host IECs.
Effects of G. intestinalis on nitric oxide production of
human IECs
Inducible nitric oxide, iNOS, encoded by nos2, is a key
enzyme in NO production during infections [10,18]. To
further investigate the observed effects on the nos2expression and iNOS activity in host cells upon Giardia
infection, effects of different arginine levels were
assessed. The growth of IECs in low-arginine medium
compared to growth with extra arginine (0.4 mM argin-
ine added to the low-arginine medium) surprisingly
showed that nos2 was highly induced on the RNA level
under low-arginine conditions (Figure 3a). The profile of
nos2 induction in low-arginine medium was similar to
the profile induced by Giardia infection with a peak of
expression after 6 h (Figure 2). Strikingly, the level of ex-
pression upon parasite-interaction was lower than in the
low-arginine medium. We therefore tested the hypoth-
esis that Giardia can induce expression of nos2 via
arginine depletion, but at the same time also down-
regulate its expression. To test this hypothesis an alter-
native model was used, where nos2 expression was first
induced in HCT-8 cells by addition of cytokines (TNF-α
(200 ng/mL), IL-1α (200 ng/mL, IFN-γ (500 ng/mL)
prior to Giardia infection (40 h later). Parasite addition
clearly and strongly down-regulated the expression of
nos2 (Figure 3b). Thus, Giardia can both induce and
down-regulate expression of iNOS.
To assess the production of NO upon iNOS induction
in Giardia-interacted human cells, the NO levels upon
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Figure 2 Expression of arginine-metabolizing enzymes in IECs upon Giardia infection. Differentiated Caco-2 IECs were in vitro infected with
Giardia trophozoites of three different assemblages (isolates WB (squares), GS (circles) and P15 (triangles)) and expression of arginine-consuming
enzymes in host cells was assessed after 0, 1.5, 3, 6 and 24 h on the RNA level by qPCR in technical quadruplicates. The data is presented as fold
change gene expression in arbitrary units on a logarithmic scale as compared to 0 h expression. GAPDH was used as reference gene. In total 12
different arginine-consuming genes and the control gene ccl20 were assessed for their expression. Note the changed scale for ccl20. adc, arginine
decarboxylase; agat, arginine-glycine amidinotransferase; arg, arginase; asl, argininosuccinate lyase; ass, argininosuccinate synthetase; cat, cationic
amino acid transporter; ccl20, chemokine (C-C motif) ligand 20; nos, nitric oxide synthase; oat, ornithine aminotransferase; oct, ornithine carbamoyl
transferase; odc, ornithine decarboxylase.
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Giardia was assessed. Trophozoites of the isolates WB,
GS and P15 were all able to completely suppress NO
production of IECs and the IECs did not recover from
this within 4 days, even though parasite survival is lim-
ited to roughly 24 h within the present interaction sys-
tem (Figure 3c). Arginine added to physiological
concentrations of 0.4 mM could partially restore the NOproduction of parasite-interacted IECs (Figure 3d). Inter-
estingly, the addition of citrulline, a metabolite of argin-
ine, to a final concentration of 0.4 mM could also
restore the capability of IECs to produce NO upon
Giardia infection (Figure 3d). Thus, Giardia can inter-
fere with the innate host immune response by consum-
ing arginine, the substrate of iNOS. Host cells try to
compensate this by inducing iNOS, but the parasite can
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Figure 3 Giardia reduces host cell nitric oxide (NO) production. A, Expression changes of inducible nitric oxide synthase (nos2) in differentia-
ted Caco-2 cells in medium with (+ arginine) and without (- arginine) arginine as assessed by qPCR in technical quadruplicates. Data is expressed
as fold change expression compared to the 0 h timepoint. Significant expression changes compared to 0 h are indicated by asterisks. B, Expres-
sion changes of nos2 upon host cell (HCT-8) stimulation with cytokines (TNF-α (200 ng/mL), IL-1α (200 ng/mL), IFN-γ (500 ng/mL)) and Giardia
infection 40 h later. Data is expressed as fold change expression compared to the 0 h unstimulated control (squares). C, NO production of host
cells (HCT-8) stimulated with cytokines 5 h after infection with Giardia trophozoites of 3 different isolates (WB, GS, P15). This experiment was re-
peated two times independently and lead to similar results. D, Giardia (isolate WB) infected host cells (HCT-8) were stimulated by cytokines to pro-
duce NO after 5 h of infection. Subsequently arginine (Arg) or citrulline (Citr) were added to 0.4 mM after 1 h of interaction. NO production was
measured 40 h later. The described experiment was repeated two times independently and lead to similar results. Significant differences in the
figure are indicated by asterisks (*for p < 0.5 and **for p < 0.01).
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the host’s NO production.
Expression of enzymes in Giardia upon IEC infection
Apart from expression changes in host IECs, we also
assessed the response of Giardia enzymes that are dir-
ectly or indirectly involved in arginine-metabolism upon
host-interaction. The three main enzymes of arginine
metabolism, ADI, OCT and CK, had previously been
shown to be initially up-regulated but later down-
regulated after host cell infection [23]. To further
investigate this and include also later time points of
interaction, trophozoites of the isolate WB were let to
interact with differentiated Caco-2 cells for 1.5, 3, 6 and
24 h. Corresponding parasite controls were conducted
in host cell medium. Thereby, the parasite genes adi, oct
and ck were down-regulated on the RNA level compared
to control samples already after 1.5-3 h (Figure 4,
Additional file 1: Table S5). Thus, the down-regulation
of the expression of parasite arginine metabolizing en-
zymes occurs at the same time as arginine is depleted in
the growth medium, showing that not only host cells,but also parasite cells, are changing the expression of
arginine-consuming enzymes upon interaction.
Further NO-defending mechanisms of Giardia
To test whether the parasite G. intestinalis also uses
other mechanisms than consuming arginine and chan-
ging iNOS expression to combat the antimicrobial
host-NO response, the expression of the NO-detoxifying
enzyme flavohemoglobin [13,14] (FlHb) was assessed.
Giardia trophozoites were interacted with host IECs
that were previously induced to produce NO by addition
of cytokines (as described above). Compared to
non-stimulated IEC controls, Giardia trophozoites up-
regulated FlHb expression on the RNA and protein level
(Figure 5) when the IECs produced NO. This could pro-
vide another layer of NO protection for the parasite
(Figure 1).
Proliferation of arginine-deprived PBMC
To assess effects of the local arginine-deprivation
caused by Giardia on infiltrating lymphocytes, periph-
eral blood mononuclear cells (PBMCs) were incubated
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Figure 4 Expression of arginine-metabolizing enzymes in Giardia
trophozoites upon host-cell interaction. Differentiated Caco-2 IECs
were infected with Giardia trophozoites (isolate WB) and expression of
arginine-consuming enzymes (adi, arginine deiminase; oct, ornithine
carbamoyltransferase; ck, carbamate kinase) was assessed at 0, 1.5, 3, 6
and 24 h on the RNA level by qPCR in technical quadruplicates.
GL50803_17364 was used as reference gene. Fold change gene
expression is shown with substracted medium effects.
Figure 5 Giardia up-regulates flavohemoglobin upon nitric
oxide (NO) stress. Human intestinal epithelial cells (HCT-8) were
stimulated for NO production by addition of cytokines (TNF-α
(200 ng/mL), IL-1α (200 ng/mL), IFN-γ (500 ng/mL)). Giardia
trophozoites of the isolate WB were added to the NO-producing
host cells and to control cells after 40 h. Samples were measured
for expression of the NO-detoxifying protein flavohemoglobin (FlHb)
at indicated time points. A, Upon interaction with NO-producing
cells FlHb was induced in trophozoites on the RNA level compared
to the control gene GL50803_17364 as assessed by qPCR in technical
quadruplicates. This highly significant difference is indicated by
asterisks. B, Western blot detecting the expression of FlHb and the
control protein Tat1 in Giardia upon interaction with HCT-8 cells
with and without NO-induction. C, Quantification of the Western
blot bands (B) by image J software clearly shows the induction
of FlHb protein in Giardia trophozoites upon interaction with
NO-induced host cells. The results are representative for similar
results obtained by three independent experiments.
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T cell activating anti-CD3 and anti-CD28 antibodies.
The GiADI used for this experiment was produced in
and purified from Giardia trophozoites and exhibited
in vitro arginine-degrading activity as earlier described
[7]. There was a dose-dependent repression of T-cell
specific PBMC proliferation upon addition of GiADI to
PBMCs that reached full effect at 5 μg/mL GiADI
(data not shown). This GiADI-dependent repression of
PBMC proliferation after T-cell specific stimulation
could be reduced by the addition of arginine to 0.4 mM,
and partially also by citrulline to 0.4 mM (Figure 6).
Respective buffer and denatured protein controls showed
no significant inhibitory effects (Figure 6).
Discussion
The fact that Giardia consumes arginine as an energy
source is well-known [8,24]. However, possible roles of
arginine in the pathophysiology of the host have only re-
cently caught attention [2,7]. Within the present study
we therefore assessed the effects of Giardia-infection of
human IECs on the expression of arginine-metabolizing
enzymes. Since gene expression changes during the very
first hours of infection can only be studied in vitro, we
used the in vitro interaction system described in [2,7].
We focused on changes on the RNA level since we ear-
lier identified large changes in host cell gene expression
already after 1.5 h [20] and early changes of gene expres-
sion are best detectable on the RNA level. As shown
in Figure 2, most of the host arginine-metabolizing
genes were unaffected or slightly down-regulated upon
Giardia-infection. nos2, the inducible form of the nitric
oxide synthases (iNOS), was induced after 3 and 6 h of
parasite interaction, but down-regulated after 24 h tolevels slightly lower than before interaction. We detected
a similar induction of nos2 expression in IECs cultivated
without arginine as compared to cells grown with argin-
ine, peaking at 6 h (Figure 3). When we induced iNOS
expression in host IECs by addition of cytokines,
Giardia trophozoites immediately down-regulated this
expression (Figure 3), which is not in accordance with
earlier results [10], however, fewer parasites per IEC, a
different cell line (HT-29), different cytokine concentra-
tions and another experimental approach with measure-
ments after 18 h was used in that study. Thus, Giardia
infection on one hand immediately induces iNOS by
arginine-depletion, but at the same time there are also
iNOS down-regulating mechanisms in the parasite.
Accordingly, iNOS expression was down-regulated in
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Figure 6 Giardia ADI reduces PBMC proliferation through
arginine consumption. The secreted Giardia protein ADI (GiADI)
was expressed and purified from Giardia WB trophozoites. T-cells
of human PBMCs of 5 blood donors were stimulated to proliferate
by activating anti-CD3 and anti-CD28 (indicated by +) and the
proliferation was assessed upon incorporation of 3H-labelled
thymidine, as depicted in counts per minute (cpm) in logarithmic
scale. T-cell stimulation was successful and not inhibited by buffer
controls (+ GiADI buffer) or addition of heat denatured GiADI
(+ GiADIb). GiADI (5 μg/mL) clearly reduced PBMC proliferation after
T-cell specific stimulation, an effect that could be reversed by
addition of arginine (+ GiADI + Arg) and partially also by its metabolite
citrulline (+ GiADI + Citr). Significant differences are indicated by
* (p < 0.5) and ** (p < 0.01).
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after several weeks of infection [25,26].
As shown in Figure 2, the host’s cationic amino acid
transporter 1 (CAT1), used for arginine-uptake into host
cells, was down-regulated in an early response (1.5-3 h),
but up-regulated after 6 h of interaction. This response
of co-induction of nos2 and cat1, combined with a down-
regulation of arginases, ensures that the host cells take up
sufficient arginine for NO synthesis (Figure 1). Such a co-
induction has been shown in murine macrophages [27]
though it was claimed that CAT2 and not CAT1 is up-
regulated together with iNOS [28]. Within our study we
could not detect expression of cat2 in IECs.
A variety of microbes are known to affect the host’s
immune response by down-regulating host NO produc-
tion, either via an up-regulation of host arginases or
expression of their own arginases [18,19] that compete
for consumption of arginine with iNOS. As shown in
Figure 2, host arginases were not up-regulated upon
IEC-Giardia interaction in vitro. However, later time
points than 24 h were not included due to limitations of
the setup. Whether arginase expression is up-regulated
at later time points in vivo is, to the best of ourknowledge, unknown. Interestingly however, the expres-
sion of ODC, a downstream enzyme of arginase, was
highly up-regulated at all times (Figure 2). This might
lead to a shift of the arginine-flux away from iNOS into
polyamine synthesis [7].
Giardia infection leads to an increased expression of
odc, inos and cat1 during the first hours of interaction,
whereas other arginine-consuming enzymes are down-
regulated or constant. We therefore studied how the
parasite can defend itself against this initial response. As
shown in Figure 3, we were able to see a NO reduction
similar to Giardia-infection of IECs [10] and addition of
Giardia ADI expressed in E. coli [9]. Moreover, this ef-
fect was observed for parasites of 3 different isolates
(from humans (WB and GS) and pigs (P15)). Interes-
tingly, the observed effect could be reverted by addition
of arginine and also by its metabolite citrulline. This
finding is interesting with regards to use of citrulline as
a supplement in rehydration therapy, as discussed below.
In addition to actively taking up arginine, Giardia
consumes arginine also indirectly via the secretion of
the enzymes ADI and OCT that degrade arginine to
ornithine via citrulline [9]. Ornithine, secreted as a
final product of arginine fermentation via an arginine-
ornithine antiporter [29], has been shown to block argi-
nine transport into IECs [30] (Figure 1). Upon interaction
with host cells, the expression of arginine-consuming en-
zymes ADI, OCT and CK was down-regulated already
after 1.5 h on the RNA level (Figure 4), which is in ac-
cordance to Ringqvist et al [23]. As suggested, the ex-
pression of these enzymes might be increased shortly
after secretion (15 minutes after host-parasite inter-
action), but is down-regulated at later time points due to
depletion of arginine in the medium and due to a pos-
sible switch to glucose as main energy source [7].
It is not known to date, whether Giardia leads to a
systemic arginine-deficiency in patients, this needs to be
followed up. However, the local reduction of arginine
levels by G. intestinalis could have additional conse-
quences on the host response, the immune response in
particular, since replication and infiltration of immune
cells in the intestine might be blocked. It was recently
shown that the phenotype and cytokine production
of dendritic cells can be affected by the arginine-
metabolizing enzyme ADI from Giardia [22]. Even
though a variety of cytokines are induced upon Giardia-
host cell interaction, there is no strong intestinal inflam-
matory response exerted. Nevertheless, a role of T cells
in elimination of Giardia infection has been shown by
Singer and Nash in mice [31]. A specific T cell prolifera-
tive response to Giardia proteins in humans has been
reported [32] and it has been suggested that ADI can in-
hibit this response [33]. Indeed, we could show that the
secreted Giardia protein ADI is capable of reducing the
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stimulation (Figure 6) and thereby probably inhibit a
strong immune response in vivo. Maximum effects were
gained with a concentration of 5 μg/mL GiADI or above.
This amount of GiADI is reasonable for mimicking the
in vivo situation, since Giardia produces and releases
ADI constantly. This finding is also in accordance with
the decreased proliferation shown for T cells cultured
without L-arginine [34] that was shown to be due to
down-regulation of the CD3zeta chain of the T cell re-
ceptor. Furthermore, we were able to completely revert
the observed reduction in T cell specific stimulated
PBMC proliferation by addition of arginine to physio-
logical levels (Figure 6).
Arginine is part of certain oral rehydration formula-
tions used for treating diarrhea. However, adverse reac-
tions such as osmotic diarrhea and excessive liver urea
production [35,36] are not in favor of such a therapy. In
addition, arginine supplementation therapy might also
be beneficial for the growth of Giardia itself, since the
parasite uses arginine as an energy source. For these rea-
sons we also tested the arginine-metabolite citrulline as
an alternative supplementary therapy within this study.
Citrulline can be reverted into arginine by argininosucci-
nate synthetase (ASS) and argininosuccinate lyase (ASL),
which were both expressed in the IECs used for this
study, but not in Giardia. It is not clear up to now if cit-
rulline can also be reconverted into arginine in vivo by
human cells such as IECs, dendritic cells and T cells.
However, in children up to 3 years the arginine-
reconverting enzymes ASS and ASL are actively expres-
sed in IECs [37]. In addition, ASS and ASL were
detected in the canine intestine [38] and it was shown
that citrulline supplementation leads to increased argi-
nine levels also in IECs in adult mice [39]. Thus it is
likely, that citrulline conversion into arginine is possible
in the intestine of human adults. In accordance to this,
we could show that citrulline is capable of reversing
all the described arginine-dependent effects on NO-
production and T cell proliferation that Giardia is
exerting (Figures 3d and Figure 6). Interestingly,
the arginine-dependent block of proliferation that was
shown to be induced in IECs upon Giardia infection,
could also be reverted by citrulline [7]. Therefore citrul-
line, an abundant component of watermelon, should gain
more attention in the future to be used as a supplement
in oral rehydration solutions. It could help generating a
proper immune response against Giardia and inhibiting
pathophysiological effects in the intestinal epithelium
that are caused by arginine-consumption of Giardia.
Conclusion
The findings presented here, and earlier data, clearly
show that Giardia interferes with a proper host immuneresponse of the host intestinal epithelium on the innate
and adaptive immunity level by affecting arginine in the
intesine on multiple levels (Figure 1). The parasite con-
sumes arginine as an energy source [7,24] and thereby
the substrate for NOS [10]. Giardia trophozoites release
arginine-consuming enzymes ADI and OCT [9] and or-
nithine that blocks the host cell transporter for arginine
uptake [29]. Expression of iNOS is initially induced but
reduced by the parasite at later stages of infection. Ex-
pression of ODC is also induced, further shifting
arginine-flux away from iNOS. Flavohemoglobin expres-
sion is induced in Giardia early upon NO-stress [13].
Dendritic cell cytokine production [22] and T cell prolif-
eration is affected due to reduced arginine-availability.
All the observed effects might not be overwhelmingly
strong by themselves, but the sum of them will certainly
protect the parasite from the host’s response.
Methods
Ethics statement
Individuals contributing peripheral blood mononuclear
cells (PBMC) for the study of T cell proliferation gave
written consent in a standard form upon registration as
blood donors. The study and consent procedure was ap-
proved by the Regional Committee for Ethics in Medical
Research (REK), Bergen, Norway.
Reagents and cell culture
If not stated otherwise, all chemicals and reagents were
purchased from Sigma Chemical Co, USA. G. intestinalis
trophozoites (strain WB, clone C6 (ATCC30957), strain
GS, clone H7 (ATCC50581) and strain P15 were main-
tained in Giardia growth medium, TYDK, as described
in Stadelmann et al [7]. G. intestinalis trophozoites were
used for interaction with human intestinal epithelial
cells (IECs) when reaching confluence. They were
washed in PBS twice and counted before dilution in
complete DMEM (high-glucose DMEM with 10% fetal
bovine serum (Gibco®, Invitrogen, Paisley, UK), 4 mM L-
glutamine, 1 × MEM non-essential amino acids, 160 μg/mL
streptomycin and 160 U/mL penicillin G) and addition
to IECs at indicated numbers. IEC cell lines CaCo-2,
clone TC7 and HCT-8 (ATCC CCL-244), were main-
tained as described in Stadelmann et al [2,7], at 37°C, 5%
CO2, in humid atmosphere, the same conditions that
were applied for interaction experiments.
Giardia – IEC interaction: gene expression
For assessment of gene expression of G. intestinalis in-
fected human IECs, Caco-2 cells were cultured in T25
tissue culture flasks 21 days post confluence with
medium changes twice per week to allow differentiation
[9]. Before addition of parasites, IECs were washed in
prewarmed DMEM. Subsequently, 7.1×106 parasites
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complete DMEM with parasites only. Samples for RNA
extraction were taken after 0, 1.5, 3, 6 and 24 h of inter-
action. Therefore, parasites were detached on ice for
10 min, supernatant was removed and human IECs were
washed twice in cold PBS before being taken up in 1 mL
TRIZOL® (Invitrogen) and stored at -20°C until further
RNA extraction. To extract parasite RNA and protein,
the supernatant of interactions including detached para-
sites was centrifuged at 500×g, 4°C, for 10 min and
taken up in 1 mL TRIZOL®.
To assess the expression status of arginine-consuming
enzymes in human IECs as well as parasite genes induced
upon interaction, RNA was extracted from each respective
interaction sample according to the standard TRIZOL
protocol. cDNA was prepared and qPCR performed as
described in Stadelmann et al [7]. Primers are given in
Additional file 1: Table S1. Human gapdh (X01677) and
G. intestinalis WB ribosomal protein S26 (GL50803_17364)
were used as reference genes [7,23]. Host cell gene expres-
sion was related to the 0 h expression value. Parasite gene
expression was expressed relative to the expression of
parasites kept in complete DMEM.
Gene expression in low-arginine medium
To assess the expression of nos2 under low arginine-
conditions, Caco-2 cells were differentiated as described
above in complete DMEM over 21 d in culture flasks,
with medium changes twice per week. Thereafter, cells
were washed in PBS and the medium was changed to
low-arginine medium (RPMI 1640 (with L-glutamine,
without arginine, leucine, lysine or phenol red) supple-
mented with 10% fetal bovine serum, 160 μg/mL
streptomycin, 160 U/mL penicillin G, 0.4 mM L-lysine
and 0.38 mM L-leucine) or low-arginine medium sup-
plemented with 0.4 mM L-arginine as described in
Stadelmann et al, 2012 [7]. Samples for RNA extraction
were taken after 0, 1.5, 3, 6 and 24 h and nos2 expres-
sion assessed by qPCR as described above.
Giardia – IEC interaction: nitric oxide production
To compare the amounts of nitric oxide (NO) produc-
tion upon interaction of IECs with different parasite iso-
lates, 5×106 HCT-8 cells were seeded in T25 tissue
culture flasks and grown to pre-confluence for 5 days.
3×106 parasites (isolates WB, GS and P15) were added
to each flask, including PBS controls. 5 h later cells were
stimulated for NO production by adding cytokines
(TNF-α (200 ng/mL), IL-1α (200 ng/mL; Santa Cruz
Biotechnology), IFN-γ (500 ng/mL; Santa Cruz Biotech-
nology)). Supernatants for NO measurement were taken
after 2, 3 and 4 days of incubation, centrifuged for
10 min at 500×g and supernatants stored at – 20°C until
measurement. Therefore triplicates of each sample weremeasured. 100 μL of the supernatant was reduced by
100 μL of nitrate reductase mix including 0.06 U/mL ni-
trate reductase from Arabidopsis thaliana, 2.5 μM FAD
and 100 μM NADPH in K2HPO4 (50 mM, pH 7.5) in 96
well plates, for 3 h at 37°C. Subsequently, nitrite was de-
tected by the Griess Reagent System (Promega, Madison,
WI) according to manufacturer’s instructions. The ab-
sorbance at 540 nm was read in a Multiskan MS Plate
Reader and nitrite concentrations were calculated ac-
cording to a standard curve. To revert the parasite in-
duced effects on NO production, arginine or citrulline
were added to 0.4 mM final concentration in the same
setup after 1 h of interaction between HCT cells and
WB parasites. Supernatants for NO measurement were
taken after 40 h of incubation and prepared and mea-
sured accordingly.Giardia-IEC interaction upon iNOS induction: gene
expression
In order to assess gene and protein expression changes
in parasite trophozoites upon host-cell induced NO-
stress, HCT-8 cells were seeded in T25 culture flasks
and cultivated and stimulated for NO-production with
cytokines as described above. After 40 h, parasites were
added to 7×106 parasites per bottle. Host cells and inter-
acted parasites were harvested after 0, 1.5, 3, 6 and 24 h.
As controls, samples were also taken from host cells that
were stimulated with cytokines but not interacted with
parasites, or not stimulated with cytokines but interacted
with parasites for the same time intervals. To assess the
expression of inos in CaCo-2 cells, these were taken up
in 1 mL TRIZOL® for further RNA extraction and qPCR
as described above. Parasites were taken up in 1 mL TRI-
ZOL® for subsequent RNA and protein extraction. cDNA
synthesis and qPCR were performed as described above.
To assess expression status of Giardia flavohemoglo-
bin also on protein level, Western blot was performed.
Protein from interaction setups was extracted from TRI-
ZOL samples and Western blot performed by blocking
of protein-containing BioTraceTM PVDF membrane
(Pall Corporation, Pensacola, FL) in 3% non-fat milk in
PBST. Proteins were detected by use of rabbit anti-Giardia-
flavohemoglobin (by courtesy of Alessandro Giuffrè,
University of Rome, Italy) 1:5’000 diluted in 0.3% non-fat
milk in PBST including also a loading control (mouse
monoclonal Tat1, 1:5,000 [40]). Secondary HRP-labeled
antibodies anti-rabbit and anti-mouse were diluted 1:8,000
and 1:10,000 respectively in 0.3% non-fat milk in PBST.
HRP was detected using Western Lightning® ECL Pro
(PerkinElmer Inc, Waltham, MA USA) and chemolumi-
nescence detected in a Universal Hood III (Bio Rad).
Semi-quantitative comparison of bands was performed by
ImageJ 1.32j.
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Peripheral blood mononuclear cells (PBMCs) were iso-
lated by density gradient separation using Lymphoprep
(Axis-Shield, Oslo, Norway) from buffycoats obtained
from 5 healthy blood donors after routine blood dona-
tion. PBMC were washed in NaCl before cells were
dissolved in X-vivo 15 serum-free culture medium sup-
plemented with L-glutamine, gentamicin and phenol red
(BioWhittaker, Walkersville, MA, USA). The freshly iso-
lated PBMC (8×104 cells/well; 200 μl medium/well) were
cultured in 96-well U-bottom microtiter plates in X-vivo
15 medium. Cells were cultured in medium alone, or in
the presence of intact functional GiADI (produced, puri-
fied and tested as described in Jerlstrom-Hultqvist et al
[41]), heat denatured (80°C for 10 min) GiADI (GiADIb),
as well as an equal dilution of BSA 1 μg/mL and PreScis-
sion enzyme containing buffer used for elution of GiADI,
in combinations with 0.4 mM arginine or citrulline and
T-cell stimulatory anti-CD3 (mouse IgE moab; CLB-T3/4.E;
final concentration 0.3 μg/mL) and anti-CD28 (mouse
IgG1moab; CLB-CD28/1; final concentration 0.8 μg/mL)
from the Central Laboratory of the Netherlands Red Cross
Blood Transfusion Services (Amsterdam, The Netherlands).
Cultures were performed in triplicates for 6 days at 37°C
in a humidified atmosphere of 5% CO2.
PBMC proliferation assay
Cellular proliferative responses were measured by the
incorporation of 3H-thymidine into newly synthesized
DNA by conventional proliferation assay [42]. After
5 days of culture cells were pulsed with 37 kBq/well of
3H-thymidine (Perkin Elmer, Boston, MA, USA) and
harvested 18 h later onto glass-fibre pads. Amounts of
DNA-incorporated radioactivity were determined by
liquid scintillation counting. Proliferation was deter-
mined as counts per minute (cpm).
Data analysis
If not mentioned otherwise, all data were analyzed using
Microsoft Office Excel 2010. Figures were prepared in
Adobe Illustrator CS4. Statistical analyses were per-
formed by two-tailed student’s t-test (p-value <0.5, sig-
nificant; < 0.01, highly significant).
Additional file
Additional file 1: Describes primers used in RT-PCR analyses (Table S1),
expressions of arginine consuming enzymes in IECs interacting with
strain WB (Table S2), GS (Table S3) and P15 (Table S4). Table S5
describes expression of arginine-consuming enzymes in Giardia WB
trophozoites during interaction with IECs.
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